Moreover, the cardioprotective and β-cell-preserving effects observed in preclinical and clinical studies underscore GLP-1R’s central role as a therapeutic target in type 2 diabetes and its comorbidities [63,64]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.